Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lucie de Jonge

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Endoscopy|August 1, 2025
Cost-effectiveness of colon capsule endoscopy in colorectal cancer screening: a modeling studyLucie de Jonge, Esther Toes-Zoutendijk, Rosita van den Puttelaar, et al.
Preventive Medicine Reports|August 21, 2023
Personalised colorectal cancer screening strategies: Information needs of the target populationEsther Toes-Zoutendijk, Lucie de Jonge, Emilie C H Breekveldt, et al.
Journal of the National Cancer Institute|August 8, 2020
Comparing the Cost-Effectiveness of Innovative Colorectal Cancer Screening TestsElisabeth F P Peterse, Reinier G S Meester, Lucie de Jonge, et al.
Preventive Medicine|July 4, 2021
The national FIT-based colorectal cancer screening program in the Netherlands during the COVID-19 pandemicTim L Kortlever, Lucie de Jonge, Pieter H A Wisse, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 24, 2023
Colorectal Cancer Stage Distribution at First and Repeat Fecal Immunochemical Test ScreeningArthur Kooyker, Lucie de Jonge, Esther Toes-Zoutendijk, et al.
British Journal of Cancer|May 12, 2021
Correction: Effects of cancer screening restart strategies after COVID-19 disruptionLindy M Kregting, Sylvia Kaljouw, Lucie de Jonge, et al.
British Journal of Cancer|March 16, 2021
Effects of cancer screening restart strategies after COVID-19 disruptionLindy M Kregting, Sylvia Kaljouw, Lucie de Jonge, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|June 15, 2024
Modelling the impact of bias in fecal immunochemical testing on long-term outcomes of colorectal cancer screeningLucie de Jonge, Esther Toes-Zoutendijk, Brechtje D M Koopmann, et al.
Journal of Medical Screening|February 1, 2022
Prioritisation of colonoscopy services in colorectal cancer screening programmes to minimise impact of COVID-19 pandemic on predicted cancer burden: A comparative modelling studyFrancine van Wifferen, Lucie de Jonge, Joachim Worthington, et al.
Gut|April 19, 2023
Impact of delayed screening invitations on screen-detected and interval cancers in the Dutch colorectal cancer screening programme: individual-level data analysisEsther Toes-Zoutendijk, Lucie de Jonge, Carola Adriana van Iersel, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Endoscopy|August 1, 2025
Cost-effectiveness of colon capsule endoscopy in colorectal cancer screening: a modeling studyLucie de Jonge, Esther Toes-Zoutendijk, Rosita van den Puttelaar, et al.
Preventive Medicine Reports|August 21, 2023
Personalised colorectal cancer screening strategies: Information needs of the target populationEsther Toes-Zoutendijk, Lucie de Jonge, Emilie C H Breekveldt, et al.
Journal of the National Cancer Institute|August 8, 2020
Comparing the Cost-Effectiveness of Innovative Colorectal Cancer Screening TestsElisabeth F P Peterse, Reinier G S Meester, Lucie de Jonge, et al.
Preventive Medicine|July 4, 2021
The national FIT-based colorectal cancer screening program in the Netherlands during the COVID-19 pandemicTim L Kortlever, Lucie de Jonge, Pieter H A Wisse, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 24, 2023
Colorectal Cancer Stage Distribution at First and Repeat Fecal Immunochemical Test ScreeningArthur Kooyker, Lucie de Jonge, Esther Toes-Zoutendijk, et al.
British Journal of Cancer|May 12, 2021
Correction: Effects of cancer screening restart strategies after COVID-19 disruptionLindy M Kregting, Sylvia Kaljouw, Lucie de Jonge, et al.
British Journal of Cancer|March 16, 2021
Effects of cancer screening restart strategies after COVID-19 disruptionLindy M Kregting, Sylvia Kaljouw, Lucie de Jonge, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|June 15, 2024
Modelling the impact of bias in fecal immunochemical testing on long-term outcomes of colorectal cancer screeningLucie de Jonge, Esther Toes-Zoutendijk, Brechtje D M Koopmann, et al.
Journal of Medical Screening|February 1, 2022
Prioritisation of colonoscopy services in colorectal cancer screening programmes to minimise impact of COVID-19 pandemic on predicted cancer burden: A comparative modelling studyFrancine van Wifferen, Lucie de Jonge, Joachim Worthington, et al.
Gut|April 19, 2023
Impact of delayed screening invitations on screen-detected and interval cancers in the Dutch colorectal cancer screening programme: individual-level data analysisEsther Toes-Zoutendijk, Lucie de Jonge, Carola Adriana van Iersel, et al.
Pageof 4